StockData
BrightSpring Health Services, Inc. logo

BrightSpring Health Services, Inc. (BTSG) stock

BTSGNasdaqServices-Home Health Care ServicesFiscal year ends December 31Also trades as BTSGU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3045% above fair value
$66.89+6.67 (+11.08%)

Close on Oct 30, 2026Market cap $13.24BP/E 36.4Yield –

Earnings

BrightSpring Health Services's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 26, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$4.21B
+26.4% on a year earlier
Adjusted EPS, Q3 FY2026
$0.54
$0.30 a year earlier
Latest guidance
Issued
Oct 30, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of BrightSpring Health Services's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 26, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Oct 30, 2026before the open$4.21B+26.4%$0.46$0.54Release
Q2 FY2026ended Jun 30, 2026Jul 31, 2026before the open$3.87B+23.0%$0.38$0.45Release
Q1 FY2026ended Mar 31, 2026May 1, 2026before the open$3.61B+25.6%––Release
Q4 FY2025ended Dec 31, 2025Feb 27, 2026before the open$3.55B+16.3%$0.35$0.33Release
Q3 FY2025ended Sep 30, 2025Oct 28, 2025during market hours$3.33B+14.7%$0.17$0.30Release
Q2 FY2025ended Jun 30, 2025Aug 1, 2025before the open$3.15B+15.3%–$0.22Release
Q1 FY2025ended Mar 31, 2025May 2, 2025before the open$2.88B+11.7%$0.14$0.19Release
Q4 FY2024ended Dec 31, 2024Mar 6, 2025before the open$3.05B+28.5%$0.08$0.22Release
Q3 FY2024ended Sep 30, 2024Nov 1, 2024before the open$2.91B–-$0.04$0.11Release
Q2 FY2024ended Jun 30, 2024Aug 2, 2024before the open$2.73B–$0.10$0.10Release
Q1 FY2024ended Mar 31, 2024May 2, 2024before the open$2.58B–-$0.26$0.12Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

BrightSpring Health Services's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
Provider Segment RevenueFY2026$1.90B – $1.93B$1.88B – $1.93BLoweredJul 31, 2026
Provider Segment Revenue growthFY2026+29.7% – +31.4%+14.1% – +17.9%RaisedJul 31, 2026
RevenuesFY2026$15.90B – $16.13B–NewOct 30, 2026
Total Adjusted EBITDAnon-GAAPFY2026$850.00M – $860.00M–NewOct 30, 2026
Total Adjusted EBITDAnon-GAAPFY2026$820.00M – $845.00M$795.00M – $825.00MRaisedJul 31, 2026
Total Adjusted EBITDA growthnon-GAAPFY2026+32.8% – +36.8%+28.7% – +33.6%RaisedJul 31, 2026

Guidance vs results

The last range BrightSpring Health Services gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
FY2025Revenue$12.40B – $12.70B$12.91BΣ4QAbove range
FY2025Revenue growth+23.1% – +26.1%+14.59%Σ4QBelow range

Guidance history

Every forecast BrightSpring Health Services put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Oct 30, 2026Total Adjusted EBITDAFY2026$850.00M – $860.00MNew
Oct 30, 2026RevenuesFY2026$15.90B – $16.13BNew
Jul 31, 2026Total Adjusted EBITDAFY2026$820.00M – $845.00MRaised
Jul 31, 2026Adjusted EBITDA in 2026FY2026$35.00MLowered
Jul 31, 2026Total Adjusted EBITDA growthFY2026+32.8% – +36.8%Raised
Jul 31, 2026Provider Segment RevenueFY2026$1.90B – $1.93BLowered
Jul 31, 2026Provider Segment Revenue growthFY2026+29.7% – +31.4%Raised
Jul 31, 2026Revenues growthFY2026+17% – +19.5%Lowered
Jul 31, 2026Pharmacy Segment Revenue growthFY2026+15.3% – +17.9%Lowered
Jul 31, 2026RevenuesFY2026$15.10B – $15.43BRaised
Jul 31, 2026Pharmacy Segment RevenueFY2026$13.20B – $13.50BLowered
May 1, 2026Total Adjusted EBITDA growthFY2026+28.7% – +33.6%Raised
May 1, 2026Total Adjusted EBITDAFY2026$795.00M – $825.00MRaised
May 1, 2026Adjusted EBITDAFY2026$30.00MLowered
May 1, 2026Provider Segment RevenueFY2026$1.88B – $1.93BLowered
May 1, 2026Revenues growthFY2026+14.1% – +17.9%Lowered
May 1, 2026Pharmacy Segment Revenue growthFY2026+12.3% – +16.2%Lowered
May 1, 2026Provider Segment Revenue growthFY2026+28% – +31.4%Raised
May 1, 2026RevenuesFY2026$14.73B – $15.23BRaised
May 1, 2026Pharmacy Segment RevenueFY2026$12.85B – $13.30BLowered

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases BrightSpring Health Services filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Results
  5. Update
  6. Update
  7. Results
  8. Results
  9. Results
  10. Results
  11. News
  12. News
  13. Results
  14. Results
  15. Update